Definitive Contract 75A50122C00048
Award Date
10/1/22
Potential Completion Date
5/29/24
Potential Value
$8.7B
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...
This is a firm fixed-price delivery order awarded to Pfizer Inc. by the Defense Logistics Agency Troop Support Medical in the amount of $347,362.79. The contract has no set-aside designation. Pfizer, a large pharmaceutical company, will provide a variety of pharmaceutical products to U.S. government agencies, including COVID-19 vaccines, intravenous solutions, injections, vaccines, controlled substances, and other medical supplies. Pfizer also holds a Blanket Purchase Agreement against the...
This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the supply of adult vaccines. The contract has a ceiling value of $54,499,343.31 and an ultimate completion date of June 30, 2016. The contract does not have a set-aside designation. Pfizer, the prime contractor, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. This contract...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines for the years 2024-2025, with a contract ceiling value of $2,271.56. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. The contract supports the federal government's ongoing COVID-19 vaccination efforts, providing 0.9 mL...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, with a ceiling value of $1,135.77, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine over a period of 6 months to 4 years, with an ultimate completion date...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.9 ML Pfizer COVID-19 vaccines from 2024-2025. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order (contract award SPE2DB24FVA07) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, as the prime contractor. The order is for the provision of Pfizer's COVID-19 vaccine at a firm fixed price of $1,525.97 with a period of performance through March 25, 2024. The contract award is not associated with any set-aside designation. AmerisourceBergen Drug Corp has an existing indefinite delivery contract (IDC)...
<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded an $8.66 billion definitive contract to Pfizer Inc., doing business as Pfizer, for COVID-19 Adult MDV Vaccine. The contract is a firm fixed price agreement with a place of performance in New York, NY. The period of performance spans from June 29, 2022 through February 29, 2024. No subcontractors were identified.</p>
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to support the 2024-2025 vaccination campaign. The $1,092.06 delivery order was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at up to $999,999,999 for a range of pharmaceutical products and medical supplies, including vaccines, to support military healthcare programs. The...